Liyun Yuan, MD, PhD

Title(s)Assistant Professor of Clinical Medicine
SchoolKeck School of Medicine of Usc
AddressHCC 261 1510 San Pablo Street Mail Code:9198
Health Sciences Campus
Los Angeles CA 90089
vCardDownload vCard

    Collapse Biography 
    Collapse Awards and Honors
    Rho Chi Pharmacy Honor Society2004Member
    2005Charles and Charlotte Krown Fellowship
    American Association of Pharmaceutical Sciences2006Graduate Student Award

    Collapse Overview 
    Collapse Overview
    Dr. Yuan is a transplant hepatologist specializing in caring for patients with chronic liver diseases, hepatocellular carcinoma, and pre-/post liver transplantation. She completed her internship and residency training in Internal Medicine at Keck USC School of Medicine, where she further finished gastroenterology fellowship training. After that, she took an extra year advanced training in transplant hepatology at University of Colorado, Denver.

    Dr. Yuan’s clinical research interests include Nonalcoholic fatty liver disease, autoimmune hepatitis and outcome of liver transplantation. She has authored several articles in peer-reviewed journals on various topics in liver disease and liver transplantation. Dr. Yuan's research activities include searching and validating diagnostic markers and prognostic makers in nonalcoholic steatohepatitis, liver targeting of anti-fibrotic therapy, and the role of PGAM5 in hepatic cell death- using the model of acetoaminophen-induced liver injury.

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Portrait of Regional Trends in Liver Transplantation for Nonalcoholic Steatohepatitis in the United States. Am J Gastroenterol. 2022 03 01; 117(3):433-444. Yuan L, Hanlon CL, Terrault N, Alqahtani S, Tamim H, Lai M, Saberi B. PMID: 35083985.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    2. Nonalcoholic Fatty Liver Disease: The Role of Visceral Adipose Tissue. Clin Liver Dis (Hoboken). 2022 Mar; 19(3):106-110. Hanlon CL, Yuan L. PMID: 35355841; PMCID: PMC8958250.
      View in: PubMed   Mentions:
    3. Racial disparities in bariatric surgery postoperative weight loss and patient satisfaction. Am J Surg. 2022 05; 223(5):969-974. Samaan JS, Abboud Y, Yuan L, Toubat O, Mirocha J, Qian E, Lee N, Subramanyam C, Samakar K. PMID: 34583849.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Two Faces of Pioglitazone: Sorting Out the Roles of its PPAR? Binding Versus Mitochondrial Pyruvate Carrier Inhibition Is Not So Simple. Hepatol Commun. 2022 Nov; 6(11):3003-3005. Yuan L, McCommis KS, Neuschwander-Tetri BA. PMID: 34558836; PMCID: PMC9592781.
      View in: PubMed   Mentions:
    5. No Foul Play for Transjugular Intrahepatic Portosystemic Shunts in Liver Transplantation for Hepatocellular Carcinoma. Liver Transpl. 2021 11; 27(11):1680-1681. Zhou K, Hanlon CL, Zhou S, Dodge JL, Kwon YK, Yuan L. PMID: 34115432.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Metabolic Risk Profiles for Hepatic Steatosis Differ by Race/Ethnicity: An Elastography-Based Study of US Adults. Dig Dis Sci. 2022 07; 67(7):3340-3355. Zhou K, Dodge JL, Yuan L, Terrault NA. PMID: 34173916.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    7. Applying the original model for end-stage liver disease score rather than the model for end-stage liver disease-Na score for risk stratification prior to transjugular intrahepatic portosystemic shunt procedures. Eur J Gastroenterol Hepatol. 2021 04 01; 33(4):541-546. Lee BT, Yang AH, Urban S, Kim KY, Ter-Oganesyan R, Yuan L, Han HH, Khemichian S, Kahn JA, Kim B. PMID: 32398491.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    8. PNPLA3 and nonalcoholic fatty liver disease: towards personalized medicine for fatty liver. Hepatobiliary Surg Nutr. 2020 Jun; 9(3):353-356. Yuan L, Terrrault NA. PMID: 32509828; PMCID: PMC7262620.
      View in: PubMed   Mentions:
    9. NAFLD in women: Unique pathways, biomarkers and therapeutic opportunities. Curr Hepatol Rep. 2019 Dec; 18(4):425-432. Yuan L, Kardashian A, Sarkar M. PMID: 32523869; PMCID: PMC7286566.
      View in: PubMed   Mentions: 2  
    10. IgG:IgM Ratios of Liver Plasma Cells Reveal Similar Phenotypes of Primary Biliary Cholangitis With and Without Features of Autoimmune Hepatitis. Clin Gastroenterol Hepatol. 2021 02; 19(2):397-399. Lee BT, Wang Y, Yang A, Han H, Yuan L, Donovan J, Kaplowitz N, Kanel G, Kahn J, Dara L. PMID: 31751773; PMCID: PMC7231645.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    11. Bile acid receptors and nonalcoholic fatty liver disease. World J Hepatol. 2015 Dec 08; 7(28):2811-8. Yuan L, Bambha K. PMID: 26668692; PMCID: PMC4670952.
      View in: PubMed   Mentions: 30  
    12. Mechanisms of drug-induced liver injury. Clin Liver Dis. 2013 Nov; 17(4):507-18, vii. Yuan L, Kaplowitz N. PMID: 24099014; PMCID: PMC3793205.
      View in: PubMed   Mentions: 66     Fields:    Translation:HumansAnimals
    13. Regulation of drug-induced liver injury by signal transduction pathways: critical role of mitochondria. Trends Pharmacol Sci. 2013 Apr; 34(4):243-53. Han D, Dara L, Win S, Than TA, Yuan L, Abbasi SQ, Liu ZX, Kaplowitz N. PMID: 23453390; PMCID: PMC3622802.
      View in: PubMed   Mentions: 64     Fields:    Translation:HumansAnimalsCells
    14. Glutathione in liver diseases and hepatotoxicity. Mol Aspects Med. 2009 Feb-Apr; 30(1-2):29-41. Yuan L, Kaplowitz N. PMID: 18786561.
      View in: PubMed   Mentions: 95     Fields:    Translation:HumansAnimalsCells
    15. Reversible lipidization of somatostatin analogues for the liver targeting. Eur J Pharm Biopharm. 2008 Oct; 70(2):615-20. Yuan L, Wang J, Shen WC. PMID: 18614343.
      View in: PubMed   Mentions: 3     Fields:    Translation:Animals
    16. Lipidization of human interferon-alpha: a new approach toward improving the delivery of protein drugs. J Control Release. 2008 Jul 02; 129(1):11-7. Yuan L, Wang J, Shen WC. PMID: 18448186.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    17. Reversible lipidization prolongs the pharmacological effect, plasma duration, and liver retention of octreotide. Pharm Res. 2005 Feb; 22(2):220-7. Yuan L, Wang J, Shen WC. PMID: 15783069.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimals
    Liyun's Networks
    Concepts (71)
    Derived automatically from this person's publications.
    _
    Co-Authors (17)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _